AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE782.05-6.2 (-0.79 %)
PREV CLOSE ( ) 788.25
OPEN PRICE ( ) 789.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 55404
TODAY'S LOW / HIGH ( )779.85 793.20
52 WK LOW / HIGH ( )527.05 830
NSE783.10-5.85 (-0.74 %)
PREV CLOSE( ) 788.95
OPEN PRICE ( ) 792.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 783.10 (238)
VOLUME 1819565
TODAY'S LOW / HIGH( ) 780.35 793.40
52 WK LOW / HIGH ( )527 830.45
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
18Jan Suyog Telematics, Sundram Fasteners an
Suyog Telematics has successfully able to obtain License from Mumbai Met..
18Jan Aurobindo Pharma’s arm to acquire port
Acrotech Biopharma LLC, a wholly owned subsidiary of Aurobindo Pharma US..
18Jan Aurobindo Pharma gains on the bourses
Aurobindo Pharma is currently trading at Rs. 780.00, up by 5.70 points o..
07Jan Aurobindo Pharma informs about investo
Aurobindo Pharma has informed that the company is participating in the 3..
02Jan Aurobindo Pharma’s arm recalls 80 lots
Aurobindo Pharma’s subsidiary -- Aurobindo Pharma USA Inc is recalling 8..
Financials
Rs. in Millions
QTR Sep 18 ANNUAL 18
Net Profit3809.518127.7
Gross Profit 4794.1 23429.4
Operating Profit 6111.527506.6
Net Sales 31703.9103031.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 1650.90 (2.65%)
M.Cap (Rs. in Cr)4127.25
Piramal Enterprises (BSE)
 2360.25 (1.09%)
M.Cap (Rs. in Cr)43333.78
Fredun Pharma (BSE)
 400.30 (5.91%)
M.Cap (Rs. in Cr)159.71
TTK Healthcare (BSE)
 770.30 (2.03%)
M.Cap (Rs. in Cr)1088.46
Sun Pharma Inds. (BSE)
 430.75 (3.04%)
M.Cap (Rs. in Cr)103351.07
Shareholding Pattern
PROMOTERS 51.87%
MUTUAL FUNDS/UTI 14.13%
NON-INSTITUTION 13.62%
FI/BANKS/INSURANCE 0.31%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.